BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8131154)

  • 1. Novel serotonergic mechanisms and clinical experience with nefazodone.
    Fontaine R
    Clin Neuropharmacol; 1993; 16 Suppl 3():S45-50. PubMed ID: 8131154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
    Fontaine R; Ontiveros A; Elie R; Kensler TT; Roberts DL; Kaplita S; Ecker JA; Faludi G
    J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nefazodone and imipramine in major depression: a placebo-controlled trial.
    Rickels K; Schweizer E; Clary C; Fox I; Weise C
    Br J Psychiatry; 1994 Jun; 164(6):802-5. PubMed ID: 7952987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of anxiety and agitation symptoms during nefazodone treatment of major depression.
    Fawcett J; Marcus RN; Anton SF; O'Brien K; Schwiderski U
    J Clin Psychiatry; 1995; 56 Suppl 6():37-42. PubMed ID: 7649972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and safety: essentials in antidepressant pharmacotherapy.
    Lader MH
    J Clin Psychiatry; 1996; 57 Suppl 2():39-44. PubMed ID: 8626362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
    Sussman N; Ginsberg DL; Bikoff J
    J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic psychopharmacology of antidepressants, part 1: Antidepressants have seven distinct mechanisms of action.
    Stahl SM
    J Clin Psychiatry; 1998; 59 Suppl 4():5-14. PubMed ID: 9554316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression.
    Kent JM
    Lancet; 2000 Mar; 355(9207):911-8. PubMed ID: 10752718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
    Owens MJ; Ieni JR; Knight DL; Winders K; Nemeroff CB
    Life Sci; 1995; 57(24):PL373-80. PubMed ID: 7475971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of antidepressants: selectivity or multiplicity?
    Westenberg HG
    J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nefazodone: a new antidepressant.
    Ellingrod VL; Perry PJ
    Am J Health Syst Pharm; 1995 Dec; 52(24):2799-812. PubMed ID: 8748566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirtazapine : A Review of its Pharmacology and Therapeutic Potential in the Management of Major Depression.
    Davis R; Wilde MI
    CNS Drugs; 1996 May; 5(5):389-402. PubMed ID: 26071050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nefazodone and venlafaxine: two new agents for the treatment of depression.
    Goldberg RJ
    J Fam Pract; 1995 Dec; 41(6):591-4. PubMed ID: 7500069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide.
    Goldberg RJ
    Drugs Aging; 1997 Aug; 11(2):119-31. PubMed ID: 9259175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug.
    Taylor DP; Carter RB; Eison AS; Mullins UL; Smith HL; Torrente JR; Wright RN; Yocca FD
    J Clin Psychiatry; 1995; 56 Suppl 6():3-11. PubMed ID: 7649970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.